Intelligence Platform
Patents
Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7794998
Primate T-lymphotropic viruses
granted patentUS 7795208
Methods of using deacetylase inhibitors to promote cell differentiation and regeneration
granted patentUS 7794714
Newcastle disease virus monoclonal antibodies
granted patentUS 7790186
Plasmodium vivax hybrid circumsporozoite protein and vaccine
granted patentUS 7790764
Biologically active macrolides, compositions, and uses thereof
granted patentUS 7790735
Methanocarba cycloalkyl nucleoside analogues
granted patentUS 7790181
Live attenuated viral vaccines for Eastern Equine Encephalitis virus
granted patentUS 7790473
Biofunctionalized quantum dots for biological imaging
granted patentUS 7790182
Protein vaccines against poxviruses
granted patentUS 7785565
Metal chelators and methods of their use
granted patentUS 7786285
Recombinant vaccine against botulinum neurotoxin
granted patentUS 7781445
Synthesis of indenoisoquinoliniums and methods of use
granted patentUS 7780966
Artificial invaplex
granted patentUS 7777019
Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells
granted patentUS 7776883
Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and A
granted patentUS 7776607
Mammalian selenoprotein differentially expressed in tumor cells
granted patentUS 7776521
Coronavirus isolated from humans
granted patentUS 7776337
Bacteriocins and novel bacterial strains
granted patentUS 7771715
Recombinant vector expressing multiple costimulatory molecules and uses thereof
granted patentUS 7771956
Method for detecting the presence of a phospholipid
granted patentUS 7771729
Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant adm
granted patentUS 7767645
SH2 domain binding inhibitors
granted patentUS 7763451
Methods for preparing Bacillus anthracis protective antigen for use in vaccines
granted patentUS 7763719
Variants of humanized anti-carcinoma MAb CC49
granted